Stocktoria
EXICURE, INC. XCUR
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 2018-05-09
EXICURE, INC. statistics & valuation
Market cap$13.8M
P / B3.5×
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | — | -2446.4% | — | -6.4% | 12950.1% |
| Net margin | — | -1940.2% | — | -9.0% | 13271.6% |
| FCF margin | — | -582.0% | — | -123.7% | 7409.3% |
| Return on assets | -35.2% | -64.4% | -146.1% | -11.1% | -98.8% |
| Return on equity | -126.0% | -143.3% | -558.0% | -17.3% | -570.7% |
| Debt / equity | — | — | — | — | 0.61× |
| Current ratio | 1.19 | 4.45 | 0.81 | 6.13 | 1.28 |
| Revenue growth | -100.0% | — | -100.0% | -6068.1% | -102.9% |
Source: SEC EDGAR filings · CIK 0001698530 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.